| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| Other Sizes |
|
| Targets |
PAD[1].
|
|---|---|
| ln Vivo |
In MRL/lpr mice, BB-Cl-Amidine hydrochloride treatment somewhat decreased splenomegaly, although PAD inhibitor treatment tended to raise the amount of anti-NET antibodies in the bloodstream. Body weight and total IgG levels were unaffected by any PAD inhibitor, though. Actually, endothelium-dependent vasodilation was markedly enhanced by treatment with Cl-amidine and BB-Cl-Amidine hydrochloride. Strong IRG down-regulation was also observed in the BB-Cl-Amidine hydrochloride group. In many cases, treatment with either Cl-amidine or BB-Cl-amidine can completely avoid or greatly improve muzzle alopecia [1].
|
| Animal Protocol |
Animal/Disease Models: MRL/lpr mice[1].
Doses: 1 mg/kg. Route of Administration: subcutaneous (sc)injection daily from 8 to 14 weeks of age. Experimental Results: Dramatically improved endothelium-dependent vasorelaxation and demonstrated a strong trend towards downregulation of IRGs. |
| References |
| Molecular Formula |
C26H27CL2N5O
|
|---|---|
| Molecular Weight |
496.431483507156
|
| Exact Mass |
495.159
|
| CAS # |
2436747-41-8
|
| Related CAS # |
BB-Cl-Amidine;1802637-39-3
|
| PubChem CID |
138377546
|
| Appearance |
White to off-white solid powder
|
| Hydrogen Bond Donor Count |
4
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
9
|
| Heavy Atom Count |
34
|
| Complexity |
645
|
| Defined Atom Stereocenter Count |
1
|
| SMILES |
ClC/C(/N)=N\CCC[C@@H](C1=NC2C=CC=CC=2N1)NC(C1C=CC(C2C=CC=CC=2)=CC=1)=O.Cl
|
| InChi Key |
APVHRPHXTLAIRI-BQAIUKQQSA-N
|
| InChi Code |
InChI=1S/C26H26ClN5O.ClH/c27-17-24(28)29-16-6-11-23(25-30-21-9-4-5-10-22(21)31-25)32-26(33)20-14-12-19(13-15-20)18-7-2-1-3-8-18;/h1-5,7-10,12-15,23H,6,11,16-17H2,(H2,28,29)(H,30,31)(H,32,33);1H/t23-;/m0./s1
|
| Chemical Name |
N-[(1S)-4-[(1-amino-2-chloroethylidene)amino]-1-(1H-benzimidazol-2-yl)butyl]-4-phenylbenzamide;hydrochloride
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : 50 mg/mL (100.72 mM)
H2O : 5 mg/mL (10.07 mM) |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.04 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (5.04 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (5.04 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.0144 mL | 10.0719 mL | 20.1438 mL | |
| 5 mM | 0.4029 mL | 2.0144 mL | 4.0288 mL | |
| 10 mM | 0.2014 mL | 1.0072 mL | 2.0144 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
